Broadridge Financial Solutions, Inc.
BR is executing well and FY27 earnings power is improving, but at $182.18 the stock already discounts much of that progress and sits above the $175.84 high-confidence base value.
BR is a quality business in a decent place operationally. The core engine is recurring, deeply embedded, and still taking share in the workflows that matter to brokers, issuers, and asset managers. That is visible in the numbers. Q4 recurring revenue grew 8% constant currency, backlog climbed to $470M, and platform-enabled innovation sales rose 60% to nearly 40% of closed sales. DLR is another proof point. Daily volume hit $360B in June, and management expects 50% growth by December as more Tier 1 banks onboard.
The earnings setup into FY27 is also healthy. Management is guiding to 6%-8% recurring revenue growth, 8%-12% adjusted EPS growth, and ~21% adjusted operating margin, versus 20.5% in FY26. That matters because BR already delivered 13.3% FY26 EPS growth to $9.67 on only 4.0% revenue growth, which implies the model still has operating leverage. The planned $25M of AI productivity gains should help absorb investment needs while protecting earnings growth. This is not an AI-disrupted story today. It is an AI-efficiency story inside an already sticky workflow business.
The problem is the stock, not the company. At $182.18, BR trades on 18.8x P/E, slightly below the 19.9x peer average, but that modest discount is not enough to create upside when the engine's high-confidence target is $175.84. The stock has also already moved hard, up 26.41% in one month and 21.68% in three months, even though FY27 still includes normalization in event-driven revenue to $250M-$300M and a tough Q1 comparison against $114M last year. With the 10-year Treasury at 4.69%, stable compounders do not get the same valuation forgiveness they did in a lower-rate tape.
The case depends on three things: backlog converting cleanly, margin stepping up toward 21%, and newer products like DLR and platform-enabled innovation becoming a bigger share of growth. Those are plausible. Management has earned credibility through 8 straight beats. But at this price, the market is already paying for much of that. That keeps the call at HOLD, not because the business lacks quality, but because the entry point lacks enough discount to fair value.
Recurring revenue tracks near 8%, DLR and platform innovation scale faster, and investors lean toward the $196.97 DCF and $188.01 quality-adjusted valuation range.
BR delivers within FY27 guidance, margin reaches about 21%, and valuation stays near current earnings multiples without a rerating.
Event-driven revenue lands near $250M, Q1 softness carries forward, and the stock derates toward the lower valuation methods, closer to the $153.69 P/S anchor.
Quant call (HOLD) diverges from analyst consensus (Strong Buy: 3 buy / 2 hold / 0 sell) — resolve explicitly.
We suffer more often in imagination than in reality.
FY27 earnings power is improving faster than the trailing numbers show, with management guiding to 8%-12% adjusted EPS growth and ~21% adjusted operating margin, so the forward P/E is lower than the trailing 18.8x and not demanding for a sticky workflow business. The issue is that the market has already started to pay for that improvement after the recent rally, while event-driven revenue normalizes and the SEC e-delivery rule change creates a modest headwind beyond FY27. The moat looks intact today because BR still sits inside regulated investor communications, proxy, wealth, and capital-markets workflows, but over 3-5 years AI is more likely to be a margin tool than a TAM unlock, with only $25M of FY27 productivity benefit currently identified. Regulation and workflow complexity remain supportive, but this still looks like a steady compounder, not a business with sharply higher terminal growth.
- FY27 guidance calls for 6%-8% recurring revenue growth, 8%-12% adjusted EPS growth, and ~21% adjusted operating margin, up from 20.5% in FY26.
- Closed sales backlog reached $470M and Q4 closed sales hit a record $158M, supporting revenue visibility into FY27-FY28.
- Valuation is reasonable on earnings at 18.8x P/E versus peer average 19.9x, but less forgiving on sales at 2.8x P/S versus peers at 1.8x, while the engine base case is $175.84, or -3.5% versus spot.
- Management guided to 8%-12% adjusted EPS growth in FY27 after FY26 EPS rose 13.3% to $9.67, showing operating leverage even with prior rate and postage pressure.
- Recurring revenue grew 8% constant currency in Q4, and management said, "We're guiding to 6% to 8% recurring revenue growth and 8% to 12% adjusted EPS growth."
- Margin should improve, with CFO guidance of "We expect adjusted operating income margin of approximately 21%, up from 20.5% in fiscal '26," helped by $25M of AI productivity gains.
- Capital markets momentum is real, DLR volume reached $360B daily in June and management expects 50% growth by December, while CQG added 3 points to Q4 Capital Markets growth.
- The stock is no longer cheap after a 26.41% 1-month move and now sits only 1.7% above its 200-day average, with the base valuation output at $175.84, below the current $182.18.
- FY27 event-driven revenue is expected to fall to $250M-$300M after a record FY26, and Q1 faces a tough comparison against $114M of event-driven revenue last year.
- Balance-sheet risk is manageable but not trivial, with Debt/EBITDA 2.70, Debt/Equity 1.24, and only 46/100 on financial health within the quality framework.
- Peer-based valuation support is weak because the average peer P/E is 19.9x across 10 peers with wide 3.9x dispersion, limiting confidence in multiple expansion from here.
| Metric | Value | Context |
|---|---|---|
| Current price | $182.18 | Reference price for valuation and scenario framing |
| Price target | $175.84 | High confidence, -3.5% versus current, basis: earnings_growth_blend |
| FY2026 revenue | $7.5B | 4.0% YoY growth |
| FY2026 EPS | $9.67 | 13.3% YoY growth |
| Operating margin | 17.4% | Up from 17.3% in prior FY |
| FY27 adjusted operating margin guide | ~21% | Management expects improvement from 20.5% in fiscal '26 on an adjusted basis |
| Valuation | P/E 18.8x, P/S 2.8x, P/B 7.38x | P/E below peer average 19.9x, P/S above peer average 1.8x |
| Leverage | Debt/EBITDA 2.70x | Moderate balance-sheet risk with total debt at $3.5B |
| Free cash flow | $1.3B | Supports $0.6B buybacks and $0.4B dividends, with capex only $0.1B |
| FY27 guide | Recurring revenue 6%-8%, adjusted EPS 8%-12% | Event-driven revenue expected at $250M-$300M |
| Backlog and sales | Backlog $470M, Q4 closed sales $158M | Record quarter and visibility into FY27-FY28 |
| 52-week position | Range $133.83-$263.00 | Current price is -30.7% versus high and 1.7% above 200-day average |
The biggest risk to owning BR here is valuation compression, because the stock at $182.18 is above the $175.84 base target while FY27 event-driven revenue is guided down to $250M-$300M after an unusually strong FY26.
The next key catalyst is the November 3, 2026 earnings report, especially whether Q1 can absorb the $114M event-driven comp and still keep FY27 EPS growth on the 8%-12% path.
Ownership is tight, with the top three institutions holding 69.6% and insider ownership just 0.3%, which tends to reduce float volatility but also limits the signaling value of insider alignment. Short interest is modest at 3.42%, or 3.94M shares and 2.6 days-to-cover, so there is no meaningful squeeze setup. Options positioning is supportive, with a positive gamma regime and zero-gamma at $162.48, about 10.8% below spot, which suggests dealer flows are not fighting the tape right now.
Management guides to 6%-8% growth in FY27, supported by a $470M backlog and record $158M Q4 closed sales.
Normalizing after a record FY26, with a particularly tough Q1 comp against $114M last year.
Q4 growth benefited from the CQG acquisition, which added 3 points, and DLR daily volume reached $360B in June.
Sales in this category rose 60%, a sign that newer products are becoming more meaningful within the bookings mix.
FY27 guide calls for 6%-8% recurring revenue growth with continued EPS expansion.
Execution has been strong. Since the stale 2025 Q1 call, management had guided 6%-8% recurring revenue growth, 8%-12% adjusted EPS growth, about 20% adjusted operating margin, $290M-$330M closed sales, and 95%-105% free cash flow conversion for FY25. The current setup shows that the strategy largely delivered and scaled: FY26 revenue reached $7.5B, up 4.0%, EPS reached $9.67, up 13.3%, FY27 margin is now guided to ~21% from 20.5% in FY26, and closed sales are again guided at $290M-$330M after Q4 alone produced a record $158M and backlog rose to $470M from the prior $450M reference point. The earnings beat record is also unusually consistent, with 8 straight beats, including +20.8%, +18.7%, and +4.6% over the last four quarters. Direction has not changed materially, the playbook is still recurring growth plus workflow expansion, but the company is now leaning more visibly on DLR, platform innovation, and AI-led productivity.
We're guiding to 6% to 8% recurring revenue growth and 8% to 12% adjusted EPS growth.
We expect adjusted operating income margin of approximately 21%, up from 20.5% in fiscal '26.
After a slow start to the year, we accelerated nicely with a record $158 million of closed sales in Q4.
Our fiscal '27 includes $25 million in AI-driven productivity gains, primarily in our technology organization, which we expect to use to fund investments and deliver earnings growth.
We're currently onboarding multiple Tier 1 banks to our platform, and we expect 50% growth by December with further scaling as the fiscal year progresses.
BR's edge is workflow entrenchment inside regulated communications, proxy, wealth, and capital-markets infrastructure where accuracy, auditability, and switching friction matter more than headline software novelty. The moat still looks durable because backlog is $470M, recurring revenue growth is guided at 6%-8%, and Tier 1 banks are onboarding to DLR. Durability is solid, but not absolute, because the SEC e-delivery change is a real reminder that parts of the model are shaped by regulation as much as technology.
Cash generation is strong, with $1.3B of FCF on just $0.1B of capex, which gives BR room to fund dividends, buybacks, and bolt-on deals. In the latest year, the company returned $0.6B via buybacks and $0.4B via dividends, and the board raised the dividend 12% to $4.36 while expanding buyback authorization to $1.5B. That is disciplined enough, though leverage at 2.70x Debt/EBITDA argues against becoming materially more aggressive.
BR is a good business and management is executing. The stock is simply not cheap enough today to justify a fresh aggressive stance, especially with a base value of $175.84 against a market price of $182.18 and event-driven revenue set to normalize in FY27. Rated HOLD, High conviction. A move materially below the base target, or evidence that DLR, backlog conversion, and AI savings can push FY27 growth above the current 8%-12% EPS guide, would improve the setup. A miss on Q1 or any sign that recurring growth slips below the 6%-8% range would weaken it.
≣ Full research note tap to expand
Executive Summary
HOLD, High conviction. BR rates a HOLD at High conviction. The business is healthy, recurring revenue is accelerating to 6%-8% in FY27, and management has a credible beat-and-raise style record, but the stock has rebounded 26.41% in 1 month and now trades modestly above the quant-derived fair value of $175.84. Good company, less attractive entry point.
Investment Thesis
BR is a quality business in a decent place operationally. The core engine is recurring, deeply embedded, and still taking share in the workflows that matter to brokers, issuers, and asset managers. That is visible in the numbers. Q4 recurring revenue grew 8% constant currency, backlog climbed to $470M, and platform-enabled innovation sales rose 60% to nearly 40% of closed sales. DLR is another proof point. Daily volume hit $360B in June, and management expects 50% growth by December as more Tier 1 banks onboard.
The earnings setup into FY27 is also healthy. Management is guiding to 6%-8% recurring revenue growth, 8%-12% adjusted EPS growth, and ~21% adjusted operating margin, versus 20.5% in FY26. That matters because BR already delivered 13.3% FY26 EPS growth to $9.67 on only 4.0% revenue growth, which implies the model still has operating leverage. The planned $25M of AI productivity gains should help absorb investment needs while protecting earnings growth. This is not an AI-disrupted story today. It is an AI-efficiency story inside an already sticky workflow business.
The problem is the stock, not the company. At $182.18, BR trades on 18.8x P/E, slightly below the 19.9x peer average, but that modest discount is not enough to create upside when the engine's high-confidence target is $175.84. The stock has also already moved hard, up 26.41% in one month and 21.68% in three months, even though FY27 still includes normalization in event-driven revenue to $250M-$300M and a tough Q1 comparison against $114M last year. With the 10-year Treasury at 4.69%, stable compounders do not get the same valuation forgiveness they did in a lower-rate tape.
The case depends on three things: backlog converting cleanly, margin stepping up toward 21%, and newer products like DLR and platform-enabled innovation becoming a bigger share of growth. Those are plausible. Management has earned credibility through 8 straight beats. But at this price, the market is already paying for much of that. That keeps the call at HOLD, not because the business lacks quality, but because the entry point lacks enough discount to fair value.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $182.18 | Reference price for valuation and scenario framing |
| Price target | $175.84 | High confidence, -3.5% versus current, basis: earnings_growth_blend |
| FY2026 revenue | $7.5B | 4.0% YoY growth |
| FY2026 EPS | $9.67 | 13.3% YoY growth |
| Operating margin | 17.4% | Up from 17.3% in prior FY |
| FY27 adjusted operating margin guide | ~21% | Management expects improvement from 20.5% in fiscal '26 on an adjusted basis |
| Valuation | P/E 18.8x, P/S 2.8x, P/B 7.38x | P/E below peer average 19.9x, P/S above peer average 1.8x |
| Leverage | Debt/EBITDA 2.70x | Moderate balance-sheet risk with total debt at $3.5B |
| Free cash flow | $1.3B | Supports $0.6B buybacks and $0.4B dividends, with capex only $0.1B |
| FY27 guide | Recurring revenue 6%-8%, adjusted EPS 8%-12% | Event-driven revenue expected at $250M-$300M |
| Backlog and sales | Backlog $470M, Q4 closed sales $158M | Record quarter and visibility into FY27-FY28 |
| 52-week position | Range $133.83-$263.00 | Current price is -30.7% versus high and 1.7% above 200-day average |
Financial Strength
BR's financial profile is solid but not pristine. The company throws off meaningful cash, with $1.3B of FCF and just $0.1B of capex, which gives it flexibility to keep funding dividends, buybacks, and acquisitions. Profitability is stable and inching up, with reported operating margin at 17.4% and a path toward ~21% adjusted operating margin in FY27, but leverage at 2.70x Debt/EBITDA and a 1.24 current ratio mean this is not a fortress balance sheet. The read is durable cash generation, manageable leverage, and enough margin upside to offset that balance-sheet mediocrity.
Competitive Position
BR's edge is workflow entrenchment inside regulated communications, proxy, wealth, and capital-markets infrastructure where accuracy, auditability, and switching friction matter more than headline software novelty. The moat still looks durable because backlog is $470M, recurring revenue growth is guided at 6%-8%, and Tier 1 banks are onboarding to DLR. Durability is solid, but not absolute, because the SEC e-delivery change is a real reminder that parts of the model are shaped by regulation as much as technology.
Management & Guidance
Guidance is credible. Management laid out 6%-8% recurring revenue growth, 8%-12% adjusted EPS growth, ~21% adjusted operating margin, $250M-$300M of event-driven revenue, and $290M-$330M of closed sales for FY27, while acknowledging a hard Q1 setup because last year included $114M of event-driven revenue in the quarter. That tone fits the operating record, not promotional optimism, and the beat history supports confidence: BR has beaten EPS estimates in 8 straight quarters, including +20.8%, +18.7%, and +4.6% in the last year. The main caveat is that event-driven revenue is inherently lumpier than recurring lines, so Q1 noise should be expected even if the full-year framework is sound.
Segment Analysis
- Recurring revenue (Majority of revenue base): Management guides to 6%-8% growth in FY27, supported by a $470M backlog and record $158M Q4 closed sales.
- Event-driven revenue ($250M-$300M guided for FY27): Normalizing after a record FY26, with a particularly tough Q1 comp against $114M last year.
- Capital Markets (Not disclosed): Q4 growth benefited from the CQG acquisition, which added 3 points, and DLR daily volume reached $360B in June.
- Platform-enabled innovation (Nearly 40% of closed sales): Sales in this category rose 60%, a sign that newer products are becoming more meaningful within the bookings mix.
Capital Allocation
Cash generation is strong, with $1.3B of FCF on just $0.1B of capex, which gives BR room to fund dividends, buybacks, and bolt-on deals. In the latest year, the company returned $0.6B via buybacks and $0.4B via dividends, and the board raised the dividend 12% to $4.36 while expanding buyback authorization to $1.5B. That is disciplined enough, though leverage at 2.70x Debt/EBITDA argues against becoming materially more aggressive.
Management Execution & Track Record
Execution has been strong. Since the stale 2025 Q1 call, management had guided 6%-8% recurring revenue growth, 8%-12% adjusted EPS growth, about 20% adjusted operating margin, $290M-$330M closed sales, and 95%-105% free cash flow conversion for FY25. The current setup shows that the strategy largely delivered and scaled: FY26 revenue reached $7.5B, up 4.0%, EPS reached $9.67, up 13.3%, FY27 margin is now guided to ~21% from 20.5% in FY26, and closed sales are again guided at $290M-$330M after Q4 alone produced a record $158M and backlog rose to $470M from the prior $450M reference point. The earnings beat record is also unusually consistent, with 8 straight beats, including +20.8%, +18.7%, and +4.6% over the last four quarters. Direction has not changed materially, the playbook is still recurring growth plus workflow expansion, but the company is now leaning more visibly on DLR, platform innovation, and AI-led productivity.
Positioning & Flows
Ownership is tight, with the top three institutions holding 69.6% and insider ownership just 0.3%, which tends to reduce float volatility but also limits the signaling value of insider alignment. Short interest is modest at 3.42%, or 3.94M shares and 2.6 days-to-cover, so there is no meaningful squeeze setup. Options positioning is supportive, with a positive gamma regime and zero-gamma at $162.48, about 10.8% below spot, which suggests dealer flows are not fighting the tape right now.
Bull Case
- Management guided to 8%-12% adjusted EPS growth in FY27 after FY26 EPS rose 13.3% to $9.67, showing operating leverage even with prior rate and postage pressure.
- Recurring revenue grew 8% constant currency in Q4, and management said, "We're guiding to 6% to 8% recurring revenue growth and 8% to 12% adjusted EPS growth."
- Margin should improve, with CFO guidance of "We expect adjusted operating income margin of approximately 21%, up from 20.5% in fiscal '26," helped by $25M of AI productivity gains.
- Capital markets momentum is real, DLR volume reached $360B daily in June and management expects 50% growth by December, while CQG added 3 points to Q4 Capital Markets growth.
Bear Case
- The stock is no longer cheap after a 26.41% 1-month move and now sits only 1.7% above its 200-day average, with the base valuation output at $175.84, below the current $182.18.
- FY27 event-driven revenue is expected to fall to $250M-$300M after a record FY26, and Q1 faces a tough comparison against $114M of event-driven revenue last year.
- Balance-sheet risk is manageable but not trivial, with Debt/EBITDA 2.70, Debt/Equity 1.24, and only 46/100 on financial health within the quality framework.
- Peer-based valuation support is weak because the average peer P/E is 19.9x across 10 peers with wide 3.9x dispersion, limiting confidence in multiple expansion from here.
Valuation & Price Target
Engine price target $175.84 (-3.5% vs current), High confidence.
- P/E Multiple: $173.55 (28% weight)
- P/S Multiple: $153.69 (20% weight)
- Quality-adjusted: $188.01 (20% weight)
- DCF: $196.97 (12% weight)
This analysis aligns with the quant baseline HOLD. The case for upgrading to BUY is execution, because BR has posted 8 straight EPS beats, guides to 8%-12% FY27 EPS growth, and expects margin to rise to ~21% with $25M of AI savings. The reason not to override the quant call is price: the stock at $182.18 is above the high-confidence target of $175.84, peer support is noisy with 10 peers at an average 19.9x P/E and wide 3.9x dispersion, and event-driven revenue is set to normalize to $250M-$300M. Sell-side consensus remains a low-signal backdrop only, and the quant-model divergence versus that more bullish street view is best resolved by respecting valuation discipline here.
Risk Assessment
Risk score 46/100 (Moderate). The biggest risk to owning BR here is valuation compression, because the stock at $182.18 is above the $175.84 base target while FY27 event-driven revenue is guided down to $250M-$300M after an unusually strong FY26.
The Bottom Line
BR is a good business and management is executing. The stock is simply not cheap enough today to justify a fresh aggressive stance, especially with a base value of $175.84 against a market price of $182.18 and event-driven revenue set to normalize in FY27. Rated HOLD, High conviction. A move materially below the base target, or evidence that DLR, backlog conversion, and AI savings can push FY27 growth above the current 8%-12% EPS guide, would improve the setup. A miss on Q1 or any sign that recurring growth slips below the 6%-8% range would weaken it.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr